This page shows you your search results in order of date. This is page number 5.

Order by Relevance | Date

Total 2036 results found since Jan 2013.

TWiV 951: Clinical update with Dr. Daniel Griffin
In his weekly clinical update Dr. Griffin discusses Influenza incidence and vaccine effectiveness during the southern hemisphere influenza season in Chile, Nirsevimab for prevention of RSV infection in healthy late-preterm and term infants, severe Monkeypox in hospitalized patients, reinfections with different SARS-CoV-2 Omicron subvariants, impact of community masking on COVID-19 in Bangladesh, unadjuvanted intranasal spike vaccine elicits protective … TWiV 951: Clinical update with Dr. Daniel Griffin Read More »
Source: virology blog - November 5, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation influenza Long Covid marburg virus monkeypox monoclonal antibody Omicron pandemic poliovirus SARS-CoV-2 vaccine vaccine booster variant of concern Source Type: blogs

Stomach flu
A couple of weeks ago I came down with a nasty case of viral gastroenteritis, more commonly known as the stomach flu. No idea how I got it…but…I got it. Well, at least Covid wasn’t involved in my case; my family doctor told me that a (small) percentage of his patients with my symptoms had turned up positive for Covid. That would have been a most unwelcome double whammy! Petunia, October 2022 Anyway, I was quite sick for about a week, sleeping most of the time, eating nothing but bananas and toast, and watching heaps of TV series and documentaries…The cats were very helpful nurses, always by my side,...
Source: Margaret's Corner - October 31, 2022 Category: Cancer & Oncology Authors: Margaret Tags: Blogroll stomach flu Source Type: blogs

TWiV 949: Clinical update with Dr. Daniel Griffin
In his weekly clinical update Dr. Griffin discusses progress toward poliomyelitis eradication in Pakistan, polio by the numbers , influenza and COVID-19 vaccination coverage among health care personnel, phase 1/2a safety and immunogenicity of an adenovirus 26 vector RSV vaccine encoding prefusion F in adults 18–50 years and RSV seropositive children 12–24 months, receipt of first and second doses of JYNNEOS vaccine for prevention of Monkeypox, distinguishing SARS-CoV-2 persistence and reinfection, Novavax NVX-COV2373 triggers potent neutralization of Omicron sub-lineages, association between regular physical activity a...
Source: virology blog - October 29, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation influenza Long Covid marburg virus monkeypox monoclonal antibody Omicron pandemic poliovirus SARS-CoV-2 vaccine vaccine booster variant of concern Source Type: blogs

Weekly Overseas Health IT Links – 29th October, 2022.
This report presents CDC findings on telehealth use trends in 2021. It includes data from the National Health Interview Survey, a nationally representative household survey conducted throughout the year by the National Center for Health Statistics. -----https://www.usnews.com/news/health-news/articles/2022-10-13/women-older-adults-more-likely-to-use-telemedicine-in-2021Who Used Telemedicine in 2021?New data shows which groups have been most likely to use a health care option popular during the pandemic.By Christopher WolfOct. 13, 2022, at 12:01 a.m.More than 1 in 3 adults used telemedicine in the past year in 2021, ac...
Source: Australian Health Information Technology - October 29, 2022 Category: Information Technology Authors: Dr David G More MB PhD Source Type: blogs

TWiV 947: Clinical update with Dr. Daniel Griffin
In his weekly clinical update Dr. Griffin discusses the prediction of upcoming global infection burden of influenza seasons after relaxation of public health and social measures during the COVID-19 pandemic, severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters, and how successful immunomodulators for treatment of COVID-19 have opened the pathway for comparative trials.
Source: virology blog - October 22, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation influenza Long Covid marburg virus monkeypox monoclonal antibody Omicron pandemic poliovirus SARS-CoV-2 vaccine vaccine booster variant of concern Source Type: blogs

Clinical Research 101: Lecture 3
Now that we ' ve cleared away a bit of the underbrush, let ' s say you think that Eye of Newt Toe of Frog (Eontof) is potentially therapeutically useful against Creeping Crud (CC), and you want to test it. You face a whole lot of considerations. One is that you ' re going to need funding, which means you need to persuade somebody -- either the National Institutes of Health or a pharmaceutical company, most likely -- to invest in your idea. They ' re going to want to know that there ' s a reasonable chance of success with Eontof, and in the case of the pharmaceutical company that they can make money off of it, which brings ...
Source: Stayin' Alive - October 17, 2022 Category: American Health Source Type: blogs

TWiV 946: Poo vs flu
Angela Mingarelli joins TWiV to discuss whether the gut microbiota of bats confers tolerance to influenza virus infection in mice, and primate hemorrhagic fever-causing arteriviruses that can reproduce in human cells and might be capable of infecting humans.
Source: virology blog - October 16, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology arterivirus bat fecal microbiome simian hemorrhagic fever virus spillover viral viruses Source Type: blogs

Clinical Research 101: Lecture 2
 Editor ' s note: Only about 15 million people so far have gotten the new bivalent Covid booster that ' s specifically formulated against the Omega variants that are currently circulating. I got it a few days ago, Walgreen ' s was offering appointments the same day! I got the flu shot at the same time, both absolutely free. Do it!So, picking up where we left off, to determine whether an intervention is beneficial, harmful or basically useless you ordinarily need a comparison group. There are actually exceptions. You don ' t need a randomized controlled trial for parachutes when jumping out of airplanes because you alr...
Source: Stayin' Alive - October 15, 2022 Category: American Health Source Type: blogs

TWiV 945: Clinical update with Dr. Daniel Griffin
In his weekly clinical update Dr. Griffin discusses a healthcare-associated infection with Monkeypox virus, air and surface sampling for monkeypox virus in a UK hospital, misrepresentation and nonadherence regarding COVID19 public health measures, tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine, clinical, virologic, and immunologic evaluation of symptomatic rebound following Nirmatrelvir/Ritonavir treatment, early outpatient treatment with Eemdesivir in patients at high risk for severe COVID-19, Molnupiravir plus usual care versus usual care alone as early treatme...
Source: virology blog - October 15, 2022 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology antiviral coronavirus COVID-19 delta inflammation influenza Long Covid marburg virus monkeypox monoclonal antibody Omicron pandemic poliovirus SARS-CoV-2 vaccine vaccine booster variant of concern Source Type: blogs

The college football fans that beat COVID and the experts that couldn ’t
BY ANISH KOKA The COVID pandemic was supposed to herald the end of the idea that a smaller government is a better government. The experts who desperately seek to be in charge of a sprawling bureaucratic state told us that it was only a powerful central authority that could do what was needed to safeguard individual liberties at a time when a highly contagious respiratory virus was spreading across the globe. New Zealand may have imposed draconian policies that did not even allow its own citizens to return, but scenes of cheering unmasked New Zealanders stood in sharp contrast to empty seats in American stadiums when ...
Source: The Health Care Blog - October 12, 2022 Category: Consumer Health News Authors: Ryan Bose-Roy Tags: COVID-19 Health Policy College Football New Zealand Source Type: blogs

Bonus Features – October 9, 2022 – Optum completes Change Healthcare acquisition, interest in flu shots is declining, and more
This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s so much happening out there in healthcare IT we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job. News UnitedHealth Group subsidiary Optum closed its acquisition of Change Healthcare for $13 billion following an unsuccessful U.S. Department of Justice challenge of the deal. Optum first announced its intention to acquire Chan...
Source: EMR and HIPAA - October 9, 2022 Category: Information Technology Authors: Brian Eastwood Tags: C-Suite Leadership Health IT Company Healthcare IT Advata ahrq Alinea Ben Grabski BeneTalk Brigham and Women's Hospital Brightside Health CARIN Alliance Change Healthcare Communicare eClinicalWorks eCW FinThrive Forward Adv Source Type: blogs